NDAORALTABLET
Approved
May 2018
Lifecycle
Peak
Competitive Pressure
0/100
Mechanism of Action
(calcium ion antagonist or slow-channel blocker) that inhibits the transmembrane influx of calcium ions into vascular smooth muscle and cardiac muscle. Experimental data suggest that amlodipine binds to both dihydropyridine and nondihydropyridine binding sites. The contractile processes of cardiac…
Loss of Exclusivity
LOE Date
Jun 14, 2038
149 months away
Patent Expiry
Jun 14, 2038
Patent Records (1)
| Patent # | Expiry | Type | Use Code |
|---|---|---|---|
| 10350171 | Jun 14, 2038 | Product | — |